文献速递血栓与止血

将IMPROVE出血与静脉血栓栓塞症风险评估模型转化为快速节俭决策树以优化住院患者静脉血栓栓塞症预防

Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis.
PubMed 文献 · Blood Adv · 2024-01-01

研究旨在验证IMPROVE出血与静脉血栓栓塞症(VTE)风险评估模型,并将其转化为快速节俭决策树以评估VTE预防对健康结局和成本的影响。采用三种方法:ASH指南最佳证据、结合指南与南卡罗来纳医科大学(MUSC)真实世界数据的学习型健康系统范式、以及仅基于MUSC电子病历回顾性提取的真实世界数据。作者推荐将IMPROVE模型整合到医院电子病历中作为床旁工具。

要点

  • 基于IMPROVE VTE评分≥2或≥4且出血评分<7的快速节俭决策树是最有效的VTE预防策略。
  • 作者推荐将IMPROVE模型整合到医院电子病历中作为床旁工具以增强住院内科患者VTE预防。

核心结论

  • 作者推荐将IMPROVE模型整合到医院电子病历中作为床旁工具,从而增强住院内科患者的VTE预防。

研究设计与样本

  • 研究采用三种方法:ASH指南最佳证据、结合指南与MUSC真实世界数据的学习型健康系统范式、以及仅基于MUSC电子病历回顾性提取的真实世界数据。
  • 研究验证IMPROVE出血与VTE风险评估模型,并将其转化为快速节俭决策树以评估VTE预防对健康结局和成本的影响。

主要发现

  • 基于IMPROVE VTE评分≥2或≥4且出血评分<7的快速节俭决策树是最有效的VTE预防策略。

关键数值与推荐

  • 快速节俭决策树基于IMPROVE VTE评分≥2或≥4且出血评分<7。

临床怎么用

  • 作者推荐将IMPROVE模型整合到医院电子病历中作为床旁工具,从而增强住院内科患者的VTE预防。

局限性

  • ASH指出尚无风险评估模型被充分分析其对患者结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current hospital venous thromboembolism (VTE) prophylaxis for medical patients is characterized by both underuse and overuse. The American Society of Hematology (ASH) has endorsed the use of risk assessment models (RAMs) as an approach to individualize VTE prophylaxis by balancing overuse (excessive risk of bleeding) and underuse (risk of avoidable VTE). ASH has endorsed IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) risk assessment models, the only RAMs to assess short-term bleeding and VTE risk in acutely ill medical inpatients. ASH, however, notes that no RAMs have been thoroughly analyzed for their effect on patient outcomes. We aimed to validate the IMPROVE models and adapt them into a simple, fast-and-frugal (FFT) decision tree to evaluate the impact of VTE prevention on health outcomes and costs. We used 3 methods: the "best evidence" from ASH guidelines, a "learning health system paradigm" combining guideline and real-world data from the Medical University of South Carolina (MUSC), and a "real-world data" approach based solely on MUSC data retrospectively extracted from electronic records. We found that the most effective VTE prevention strategy used the FFT decision tree based on an IMPROVE VTE score of ≥2 or ≥4 and a bleeding score of <7. This method could prevent 45% of unnecessary treatments, saving ∼$5 million annually for patients such as the MUSC cohort. We recommend integrating IMPROVE models into hospital electronic medical records as a point-of-care tool, thereby enhancing VTE prevention in hospitalized medical patients.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Djulbegovic B, Boylan A, Kolo S, et al. Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis. Blood Adv. 2024. PMID: 38621198. doi:10.1182/bloodadvances.2024013166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。